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Abstract
Background: Diseases with an onset during childhood
or adult life can have their origin during fetal life or
at birth. Neonatal blood dried on filter paper (Guthrie
cards) collected for screening purposes is routinely
stored for decades. In addition to clinical use, these
filters in combination with patient registers constitute
an invaluable resource for epidemiological and patho-
physiological research. Although RNA has been suc-
cessfully recovered from such filters even after
decades of storage, the potential decay of RNA over
time has not previously been investigated using
quantitative methods.
Methods: Filter papers (ns5) with dried blood spots
from the Swedish National PKU register, stored for 1,
5, 10, 15 or 20 years were randomly selected. RNA
was isolated from each sample, quantitated by spec-
trophotometry and reverse transcribed following
DNase I treatment. Amplifiable cDNA was subse-
quently detected by real-time PCR using primers
specific for transcripts encoding b-actin.
Results: Transcripts encoding b-actin were detected
in all 25 samples analyzed at a mean threshold cycle
(Ct) of 25 (SD 1.9). A one-way ANOVA indicated no
significant effect of storage time on Ct values.
Conclusions: The lack of significant decay of RNA in
dried blood filters stored for up to 20 years suggests
that such filters are useful for studies of RNA deter-
minants of diseases with an onset in childhood as
well as adult life.
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Introduction
Since 1974, most newborn children in Sweden under-
go screening tests for severe inborn errors of metab-
olism. For this purpose, four spots of whole blood are
blotted on filter paper (i.e., Guthrie cards). A small
amount is used for analyses and the remaining spots
are stored for future clinical or research use. This
procedure is routinely used worldwide.
Many diseases with an onset during childhood or
adult life can have their origin during fetal life or birth.
For example, fetal undernutrition, resulting in low
birth weight, has been associated with increased rates
of coronary heart disease, diabetes, hypertension and
stroke later in life (1, 2). Breast cancer could have an
origin due to intrauterine hormone levels (3) and in
many childhood leukemias unknown events create a
preleukemic clone before birth (4). Intrauterine infec-
tion can result in blindness later in life (5). Since the
neonatal blood spots are collected prospectively with
no selection bias and cover almost the entire popu-
lation, they represent an invaluable resource for
epidemiological research. Also, in combination with
patient registers, they constitute a precious tool in the
search for the molecular basis of a disease. However,
the range of analytical possibilities is limited by the
small amount of blood available. Several research
groups have recovered DNA from these filter papers
following long-term storage, with subsequent molec-
ular analyses including whole genome amplification
and detection of specific mutations or genetic rear-
rangements (6–8). In 1992, Zhang and McCabe (9) and
Matsubara et al. (10) isolated RNA from dried blood
spots after up to 4 years of storage. We previously
reported that RNA that is suitable for PCR analyses
could be retrieved from dried blood spots after
27 years of storage (11). More recently, Haak and
coworkers reported that RNA amenable for quantita-
tive gene expression analyses by both real-time PCR
and microarray could be recovered from dried blood
spots stored for up to 9 years (12). We investigate the
impact of long-term storage on the amounts of RNA
that can be retrieved from dried blood filter.
Materials and methods
Filter papers with dried blood spots from the Swedish
National PKU register at the Karolinska University Hospital
Huddinge, stored for 1, 5, 10, 15 and 20 years, were random-
ly selected. Five specimens were collected for each time
point and five 3 mm punches of dried blood were obtained
from each specimen. These neonatal dried blood spots had
been stored at 48C since 1981, and in a controlled relative
humidity not exceeding 30% since 1996.
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Figure 1 Ct values obtained from an assay detecting tran-
scripts encoding human b-actin in dried blood spots accord-
ing to years of storage (ns5 for each time-point).
Figure 2 Yield of total RNA from dried blood spots accord-
ing to years of storage as determined by spectrophotometric
readings at 260 nm.
RNA was isolated from the samples with the RNeasyMicro
Kit (Qiagen, Hilden, Germany) according to the manufactu-
rer’s instructions. Briefly, filters were incubated in lysis buf-
fer at 378C for 30 min in a thermomixer (Eppendorf,
Hamburg, Germany) at 1000 rpm. The lysates were applied
to the RNeasy columns, and after careful washing, the RNA
was eluted in 14 mL of RNase-free water. This eluate was
reapplied twice to the column to maximize yield. Eight mL of
the RNA was subjected to DNase I digestion and reverse
transcribed using random hexamers as described previously
(13) with reagents from Invitrogen (Carlsbad, CA, USA).
Reactions prepared in the absence of reverse transcriptase
were prepared in parallel to verify degradation of genomic
DNA. cDNA was detected using quantitative real-time PCR
(ABI 7000 SDS, Applied Biosystems, Palo Alto, CA, USA)
with oligonucleotides designed to amplify fragments of the
mRNAs encoding human b-actin (forward 59-ATCC-
TAAAAGCCACCCCACT-39, reverse 59-CTCAAGTTGGGGGA-
CAAAAA-39), as described previously (14). All samples and
controls were run in triplicate (technical replicates). For the
purpose of these analyses, threshold cycle (Ct) values were
reported. Melting temperatures of the amplified products
were obtained in a post-amplification step.
Following successful amplification, 1 mL aliquots of each
of the remaining eluates were applied to a Nanodrop ND-
1000 spectrophotometer for quantification of RNA (Nano-
Drop Technologies, Wilmington, DE, USA).
The study was approved by the Regional Ethics Commit-
tee, Karolinska University Hospital, Karolinska Institutet,
Stockholm, Sweden.
Results
We were able to detect transcripts encoding human
b-actin in all dried blood spots, regardless of storage
time. Overall, such transcripts were detected at a Ct-
value of 25.1"1.9 (mean"SD) in the 25 samples. All
detected amplicons exhibited a uniform melting tem-
perature. Ct values for the five biological replicates
according to years of storage are shown in Figure 1.
A one-way ANOVA indicated no difference between
the groups (p)0.05), suggesting that significant RNA
decay does not occur over the 20 years period we
studied. PCR reactions following cDNA synthesis in
the absence of reverse transcriptase were consistent-
ly negative, indicating that the PCR products obtained
during real-time PCR were templated by cDNA and
confirming that DNase I treatment of the RNA effi-
ciently eliminated contaminating genomic DNA (11).
Total yield of RNA from each eluate was calculated
based on spectrophotometry. Overall, 457"171 ng of
total RNA was recovered from the dried blood spots.
Individual values according to years of storage are
shown in Figure 2. A one-way ANOVA indicated no
difference between the groups, supporting the PCR
results.
Discussion
We report that transcripts encoding b-actin are readily
detectable in RNA isolated from dried neonatal blood
spots stored for up to 20 years. In addition, as deter-
mined using real-time PCR and spectrophotometric
analyses, no significant loss of transcripts appeared
to occur over time. These results are consistent with
a previous study, where the yield of total RNA in sam-
ples stored at ambient temperature for up to 9 years
was quantified (12).
Filter papers constitute a unique resource for inves-
tigating events that may be reflected in peripheral
blood cells or plasma at the time of birth and for dis-
eases that may have an onset later in life. Even after
long-term storage, previous analyses of DNA and pro-
teins in dried blood spots have contributed to a better
understanding of the pathogenesis of a number of
diseases. For example, leukemia specific rearrange-
ments found at diagnosis of children up to the age of
15 years has been detected in stored filter papers col-
lected at birth (4). Also, antibodies and cytokines have
been analyzed in dried blood spots from patients with
schizophrenia or cerebral palsy after storage for more
than 15 years (15, 16).
No studies have investigated the usefulness of RNA
in dried blood filters, stored for up to 20 years, using
quantitative gene expression analyses. We have
shown that stored filter paper containing neonatal
blood spots may be used for studies of RNA deter-
minants of diseases with suspected origin at birth, but
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that may have an onset in childhood as well as adult
life.
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